RPS6KA1 and breast carcinoma: Our observations are in accordance with previous findings that have demonstrated RSK family members to be mediators of resistance to PI3K pathway inhibition in breast cancer, and to be capable of promoting disease progression in HNSCC specifically [35, 36].